Prediction of Risk of Depressive Symptoms in Menopausal Women Based on Hot Flash and Sweating Symptoms: a Multicentre Study

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2017 Dec 5

PMID 29200839

Authors

Yanwei Zheng

Yibei Zhou

Jiangshan Hu

Jieping Zhu

Qi Hua

Minfang Tao

Affiliations

Soon will be listed here.

Abstract

Objective: The present study aimed to develop a symptom-based (namely, hot flashes and sweating) scoring system for predicting the risk of depressive symptoms in menopausal women via a multicentre cross-sectional survey.

Methods: The data examined in the present study were obtained from 1,004 women aged 40-60 years who underwent physical examination at A Hospital. The basic information was obtained using a questionnaire-based survey. A self-rating depression scale was used to obtain the depressive symptom scores, while the Kupperman Menopausal Index was used to obtain the scores for the frequency of hot flashes and sweating. A logistic regression model was also established. The resulting β coefficient was employed to calculate and predict the risk of depressive symptoms in these women and a risk scoring system was established. The scoring system was validated using samples from 2 other centers (validation sample 1: B Hospital, 440 women; validation sample 2: C Hospital, 247 women).

Results: The scoring system developed to predict the risk of depressive symptoms in menopausal women was based on hot flash and sweating symptoms and associated with menopausal status, hot flash scores, education level (high school education and below) and being diabetic. The scoring system yielded a total score of 0-54 points. For women in the study sample, the area under the curve (AUC) of depressive symptom risk score was 0.750 (95% CI, 0.708-0.793). Validation sample 1 had an AUC of 0.731 (95% CI, 0.667-0.794), while validation sample 2 had an AUC of 0.744 (95% CI, 0.669-0.820). The optimal cut-off score to assess depressive symptoms in women participating in the present study was 31 points. The sensitivity and specificity for predicting depressive symptoms in the study sample were 0.667 and 0.701, respectively. In contrast, the sensitivity was 0.840 in validation sample 1 and 0.879 in validation sample 2.

Conclusion: The hot flash and sweating symptom-based scoring system developed to predict the risk of depressive symptoms in menopausal women relies on non-laboratory survey data. The system is simple, practical, and convenient to use. For Chinese huge population of menopausal women, the scoring system should be considered a reliable screening tool for depressive symptoms.

References

Nygaard R, Sirany A, Wyman E, Bodner J, Richardson C, Ney A . A clinical tool to risk stratify potential kidney transplant recipients and predict severe adverse events. Clin Transplant. 2016; 30(11):1494-1500. DOI: 10.1111/ctr.12848. View

Harlow S, Gass M, Hall J, Lobo R, Maki P, Rebar R . Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012; 19(4):387-95. PMC: 3340903. DOI: 10.1097/gme.0b013e31824d8f40. View

Rossler W, Ajdacic-Gross V, Riecher-Rossler A, Angst J, Hengartner M . Does menopausal transition really influence mental health? Findings from the prospective long-term Zurich study. World Psychiatry. 2016; 15(2):146-54. PMC: 4911775. DOI: 10.1002/wps.20319. View

Perich T, Roberts G, Frankland A, Sinbandhit C, Meade T, Austin M . Clinical characteristics of women with reproductive cycle-associated bipolar disorder symptoms. Aust N Z J Psychiatry. 2016; 51(2):161-167. DOI: 10.1177/0004867416670015. View

Gibson C, Joffe H, Bromberger J, Thurston R, Lewis T, Khalil N . Mood symptoms after natural menopause and hysterectomy with and without bilateral oophorectomy among women in midlife. Obstet Gynecol. 2012; 119(5):935-41. PMC: 3339661. DOI: 10.1097/AOG.0b013e31824f9c14. View

Scapagnini G, Davinelli S, Drago F, De Lorenzo A, Oriani G . Antioxidants as antidepressants: fact or fiction?. CNS Drugs. 2012; 26(6):477-90. DOI: 10.2165/11633190-000000000-00000. View

Zang H, He L, Chen Y, Ge J, Yao Y . The association of depression status with menopause symptoms among rural midlife women in China. Afr Health Sci. 2016; 16(1):97-104. PMC: 4915426. DOI: 10.4314/ahs.v16i1.13. View

Joffe H, Soares C, Cohen L . Assessment and treatment of hot flushes and menopausal mood disturbance. Psychiatr Clin North Am. 2003; 26(3):563-80. DOI: 10.1016/s0193-953x(03)00045-5. View

Brown L, Bryant C, Brown V, Bei B, Judd F . Self-compassion weakens the association between hot flushes and night sweats and daily life functioning and depression. Maturitas. 2014; 78(4):298-303. DOI: 10.1016/j.maturitas.2014.05.012. View

10.

Gibson C, Thurston R, Matthews K . Cortisol dysregulation is associated with daily diary-reported hot flashes among midlife women. Clin Endocrinol (Oxf). 2016; 85(4):645-51. DOI: 10.1111/cen.13076. View

11.

Carmignani L, Pedro A, Costa-Paiva L, Pinto-Neto A . The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial. Maturitas. 2010; 67(3):262-9. DOI: 10.1016/j.maturitas.2010.07.007. View

12.

Melby M, Anderson D, Sievert L, Obermeyer C . Methods used in cross-cultural comparisons of vasomotor symptoms and their determinants. Maturitas. 2011; 70(2):110-9. DOI: 10.1016/j.maturitas.2011.07.010. View

13.

Kalay A, Demir B, Haberal A, Kalay M, Kandemir O . Efficacy of citalopram on climacteric symptoms. Menopause. 2007; 14(2):223-9. DOI: 10.1097/01.gme.0000243571.55699.4a. View

14.

Xia Y, Wang N, Yu B, Zhang Q, Liu L, Meng G . Dietary patterns are associated with depressive symptoms among Chinese adults: a case-control study with propensity score matching. Eur J Nutr. 2016; 56(8):2577-2587. DOI: 10.1007/s00394-016-1293-y. View

15.

Sun D, Shao H, Li C, Tao M . Sleep disturbance and correlates in menopausal women in Shanghai. J Psychosom Res. 2014; 76(3):237-41. DOI: 10.1016/j.jpsychores.2013.12.002. View

16.

Davinelli S, Scapagnini G, Marzatico F, Nobile V, Ferrara N, Corbi G . Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: A randomized, placebo-controlled study. Maturitas. 2017; 96:77-83. DOI: 10.1016/j.maturitas.2016.11.016. View

17.

Joffe H, Crawford S, Freeman M, White D, Bianchi M, Kim S . Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women. J Clin Endocrinol Metab. 2016; 101(10):3847-3855. PMC: 5052351. DOI: 10.1210/jc.2016-2348. View

18.

Wu Y, Si R, Yang S, Xia S, He Z, Wang L . Depression induces poor prognosis associates with the down-regulation brain derived neurotrophic factor of serum in advanced small cell lung cancer. Oncotarget. 2016; 7(52):85975-85986. PMC: 5349890. DOI: 10.18632/oncotarget.13291. View

19.

Shors T, Leuner B . Estrogen-mediated effects on depression and memory formation in females. J Affect Disord. 2003; 74(1):85-96. PMC: 3374589. DOI: 10.1016/s0165-0327(02)00428-7. View

20.

Bromberger J, Matthews K, Schott L, Brockwell S, Avis N, Kravitz H . Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord. 2007; 103(1-3):267-72. PMC: 2048765. DOI: 10.1016/j.jad.2007.01.034. View